Profile data is unavailable for this security.
About the company
COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. It also provides tobacco and others.
- Revenue in JPY (TTM)985.18bn
- Net income in JPY26.09bn
- Incorporated1983
- Employees5.51k
- LocationCosmos Pharmaceutical Corp4F, S Kan, Daiichi Fukuoka Bldg.2-10-1, Hakataeki HigashiHakata-kuFUKUOKA-SHI 812-0013JapanJPN
- Phone+81 924330660
- Websitehttps://www.cosmospc.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kusuri No Aoki Holdings Co Ltd | 449.77bn | 12.77bn | 337.47bn | 4.74k | 24.80 | 2.48 | 13.46 | 0.7503 | 129.47 | 129.47 | 4,604.24 | 1,293.64 | 1.52 | 7.11 | 32.47 | 94,988,180.00 | 4.31 | 5.39 | 6.25 | 8.16 | 26.88 | 27.89 | 2.84 | 3.37 | 0.9561 | 68.99 | 0.4633 | 6.97 | 15.31 | 11.73 | -0.1542 | 2.94 | 4.19 | 12.54 |
| Yaoko Co Ltd | 674.17bn | 18.98bn | 388.53bn | 4.35k | 20.11 | 2.12 | 11.85 | 0.5763 | 461.14 | 461.14 | 16,473.45 | 4,383.11 | 1.96 | 41.63 | 64.26 | 155,089,500.00 | 5.61 | 5.38 | 7.31 | 7.04 | 27.73 | 28.27 | 2.87 | 2.85 | 1.02 | 37.27 | 0.2956 | 22.13 | 9.76 | 7.33 | 15.11 | 9.11 | 2.90 | 12.89 |
| Tsuruha Holdings Inc | 1.04tn | 24.81bn | 397.09bn | 11.62k | 15.78 | 1.36 | 8.69 | 0.3814 | 507.91 | 507.91 | 21,313.83 | 5,888.44 | 1.91 | 5.09 | 21.65 | 89,590,700.00 | 5.04 | 5.56 | 8.08 | 9.21 | 30.42 | 29.70 | 2.64 | 2.99 | 0.7253 | 42.62 | 0.1466 | 39.67 | 5.92 | 5.60 | -4.56 | -0.5861 | 30.80 | 12.53 |
| Sundrug Co Ltd | 775.66bn | 29.34bn | 410.50bn | 6.66k | 13.71 | 1.54 | 8.99 | 0.5292 | 250.88 | 250.88 | 6,632.09 | 2,229.34 | 1.96 | 6.45 | 32.68 | 116,429,800.00 | 7.43 | 7.88 | 10.49 | 11.55 | 25.27 | 24.86 | 3.78 | 3.82 | 0.9398 | 51.61 | 0.1166 | 38.73 | 8.88 | 5.03 | 13.32 | 4.01 | 27.84 | 11.55 |
| Sugi Holdings Co Ltd | 791.72bn | 24.77bn | 474.98bn | 8.72k | 18.26 | 1.86 | 11.86 | 0.5999 | 136.90 | 136.90 | 4,375.13 | 1,346.16 | 1.93 | 6.87 | 16.42 | 90,752,180.00 | 6.03 | 6.11 | 9.76 | 9.30 | 30.91 | 30.38 | 3.13 | 3.21 | 0.8864 | -- | 0.0439 | 23.96 | 11.51 | 8.79 | 15.64 | 4.14 | 12.58 | 2.71 |
| Cosmos Pharmaceutical Corp | 985.18bn | 26.09bn | 537.61bn | 5.51k | 20.41 | 2.25 | 11.53 | 0.5457 | 329.18 | 329.18 | 12,430.53 | 2,992.83 | 2.14 | 9.47 | 1,711.86 | 178,733,100.00 | 5.67 | 6.59 | 10.42 | 12.35 | 19.88 | 19.92 | 2.65 | 3.03 | 0.3209 | 401.07 | 0.1016 | 14.02 | 16.59 | 9.57 | 2.76 | 4.97 | 13.96 | 19.14 |
Data as of Nov 22 2024. Currency figures normalised to Cosmos Pharmaceutical Corp's reporting currency: Japanese Yen JPY
18.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 31 Jul 2024 | 3.15m | 3.93% |
| JPMorgan Asset Management (Japan) Ltd.as of 31 Oct 2024 | 2.77m | 3.46% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 2.19m | 2.74% |
| Nomura Asset Management Co., Ltd.as of 07 Nov 2024 | 1.26m | 1.57% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 31 Oct 2024 | 1.24m | 1.55% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 1.17m | 1.46% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.06m | 1.32% |
| BlackRock Investment Management LLCas of 14 Nov 2024 | 782.40k | 0.98% |
| Nikko Asset Management Co., Ltd.as of 08 Nov 2024 | 557.00k | 0.70% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 530.10k | 0.66% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
